
FDA Delays Full Approval of Novavax Covid-19 Vaccine, Requesting More Data Despite Clear Path to Clearance
The US Food and Drug Administration (FDA) has startled many by delaying the complete approval of Novavax’s COVID-19 vaccine, even though the vaccine was expected to be cleared earlier this week. According to those familiar with the matter, the FDA is currently looking for more information before concluding. The clearance procedure has been delayed for…